A detailed history of Aspect Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Aspect Partners, LLC holds 133 shares of NVO stock, worth $6,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133
Previous 63 111.11%
Holding current value
$6,445
Previous $4.35 Million 69.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$45.38 - $71.7 $3,176 - $5,019
70 Added 111.11%
133 $7.38 Million
Q2 2025

Aug 06, 2025

BUY
$58.08 - $81.05 $2,265 - $3,160
39 Added 162.5%
63 $4.35 Million
Q1 2025

Apr 24, 2025

BUY
$69.3 - $90.95 $1,316 - $1,728
19 Added 380.0%
24 $1.67 Million
Q4 2024

Feb 03, 2025

BUY
$85.0 - $120.04 $425 - $600
5 New
5 $429,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Aspect Partners, LLC Portfolio

Follow Aspect Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspect Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspect Partners, LLC with notifications on news.